Relation Between Neutrophil Counts on Admission, Microvascular Injury, and Left Ventricular Functional Recovery in Patients With an Anterior Wall First Acute Myocardial Infarction Treated With Primary Coronary Angioplasty

2007 ◽  
Vol 100 (1) ◽  
pp. 35-40 ◽  
Author(s):  
Takefumi Takahashi ◽  
Yoshikazu Hiasa ◽  
Yoshikazu Ohara ◽  
Shin-ichiro Miyazaki ◽  
Riyo Ogura ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Functional Recovery ◽  
Coronary Angioplasty ◽  
Anterior Wall ◽  
Left Ventricular ◽  
Microvascular Injury ◽  
Primary Coronary Angioplasty

scholarly journals Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection

2021 ◽  
pp. 1-4
Author(s):  
Sadeq Tabatabai ◽  
Nooshin Bazargani ◽  
Kamaleldin Al-Tahmody ◽  
Jasem Mohammed Alhashmi
Keyword(s):  
Myocardial Infarction ◽  
Health Care ◽  
Acute Myocardial Infarction ◽  
Stent Thrombosis ◽  
Coronary Angioplasty ◽  
Anterior Wall ◽  
Coronary Stent ◽  
Antithrombotic Agents ◽  
Health Care Burden ◽  
Primary Coronary Angioplasty

Soon after it was discovered in Wuhan, China, in December 2019, coronavirus disease 2019 (COVID-19) blow-out very fast and became a pandemic. The usual presentation is respiratory tract infection, but cardiovascular system involvement is sometimes fatal and also a serious personal and health care burden. We report a case of a 57-year-old man who was admitted with anterior wall acute myocardial infarction secondary to early coronary stent thrombosis and associated with COVID-19 infection. He was managed with primary coronary angioplasty and discharged home. Procoagulant and hypercoagulability status associated with severe acute respiratory syndrome coronavirus 2 infection is the most likely culprit. Choosing aggressive antithrombotic agents after coronary angioplasty to prevent stent thrombosis during the COVID-19 pandemic may be the answer but could be challenging.

Sign in / Sign up

Export Citation Format

Share Document